Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1978 2
1981 1
1993 1
1995 1
1999 1
2002 1
2003 3
2004 2
2007 2
2008 1
2009 3
2010 1
2011 2
2012 2
2013 3
2014 4
2015 4
2016 5
2017 9
2018 4
2019 10
2020 19
2021 15
2022 7
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Sialorrhea in Parkinson's Disease.
Isaacson J, Patel S, Torres-Yaghi Y, Pagán F. Isaacson J, et al. Among authors: pagan f. Toxins (Basel). 2020 Oct 31;12(11):691. doi: 10.3390/toxins12110691. Toxins (Basel). 2020. PMID: 33142833 Free PMC article. Review.
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A; LCIG Horizon Study Group. Olanow CW, et al. Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Epub 2013 Dec 20. Lancet Neurol. 2014. PMID: 24361112 Free PMC article. Clinical Trial.
Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.
Camilleri M, Subramanian T, Pagan F, Isaacson S, Gil R, Hauser RA, Feldman M, Goldstein M, Kumar R, Truong D, Chhabria N, Walter BL, Eskenazi J, Riesenberg R, Burdick D, Tse W, Molho E, Robottom B, Bhatia P, Kadimi S, Klos K, Shprecher D, Marquez-Mendoza O, Hidalgo G, Grill S, Li G, Mandell H, Hughes M, Stephenson S, Vandersluis J, Pfeffer M, Duker A, Shivkumar V, Kinney W, MacDougall J, Zasloff M, Barbut D. Camilleri M, et al. Among authors: pagan f. Ann Intern Med. 2022 Dec;175(12):1666-1674. doi: 10.7326/M22-1438. Epub 2022 Nov 8. Ann Intern Med. 2022. PMID: 36343348 Clinical Trial.
Adenosine A2A antagonists and Parkinson's disease.
Offit M, Nagle B, Ozay G, Zhang I, Kerasidis A, Torres-Yaghi Y, Pagan F. Offit M, et al. Among authors: pagan f. Int Rev Neurobiol. 2023;170:105-119. doi: 10.1016/bs.irn.2023.06.004. Epub 2023 Jul 3. Int Rev Neurobiol. 2023. PMID: 37741688
Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS.
Piotti A, Novelli D, Meessen JMTA, Ferlicca D, Coppolecchia S, Marino A, Salati G, Savioli M, Grasselli G, Bellani G, Pesenti A, Masson S, Caironi P, Gattinoni L, Gobbi M, Fracasso C, Latini R; ALBIOS Investigators. Piotti A, et al. Crit Care. 2021 Mar 19;25(1):113. doi: 10.1186/s13054-021-03545-1. Crit Care. 2021. PMID: 33741039 Free PMC article. Clinical Trial.
97 results